Russell Investments Group
AZN icon

Russell Investments Group’s AstraZeneca AZN Stock Holding History

Russell Investments Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382M Buy
2,033,587
+30,559
+2% +$5.75M 0.34% 38
2026
Q1 		$389M Buy
2,003,028
+1,633,759
+442% +$315M 0.42% 27
2025
Q4 		$67.9M Sell
369,269
-62,367
-14% -$10.9M 0.07% 260
2025
Q3 		$66.2M Buy
431,636
+2,640
+0.6% +$400K 0.08% 265
2025
Q2 		$60M Sell
428,996
-32,169
-7% -$4.51M 0.08% 262
2025
Q1 		$67.8M Buy
461,165
+15,236
+3% +$2.2M 0.09% 228
2024
Q4 		$58.4M Buy
445,929
+17,519
+4% +$2.45M 0.08% 256
2024
Q3 		$66.8M Buy
428,410
+124
+0% +$20K 0.1% 224
2024
Q2 		$66.8M Buy
428,286
+39,461
+10% +$5.94M 0.11% 195
2024
Q1 		$52.7M Sell
388,825
-261,478
-40% -$34.6M 0.08% 266
2023
Q4 		$87.6M Buy
650,303
+171,092
+36% +$22.2M 0.16% 136
2023
Q3 		$64.9M Buy
479,211
+89,788
+23% +$12.3M 0.13% 179
2023
Q2 		$55.7M Sell
389,423
-10,508
-3% -$1.55M 0.11% 209
2023
Q1 		$55.5M Buy
399,931
+14,715
+4% +$1.98M 0.11% 208
2022
Q4 		$52.2M Sell
385,216
-12,786
-3% -$1.6M 0.11% 227
2022
Q3 		$43.6M Sell
398,002
-138,337
-26% -$17.5M 0.1% 254
2022
Q2 		$70.9M Buy
536,339
+25,801
+5% +$3.39M 0.14% 167
2022
Q1 		$67.7M Sell
510,538
-104,884
-17% -$12.6M 0.12% 211
2021
Q4 		$71.7M Sell
615,422
-205,330
-25% -$24.2M 0.11% 208
2021
Q3 		$98.6M Buy
820,752
+415,688
+103% +$48.4M 0.17% 130
2021
Q2 		$48.5M Buy
405,064
+97,577
+32% +$10.7M 0.08% 301
2021
Q1 		$30.6M Sell
307,487
-129,605
-30% -$13M 0.05% 411
2020
Q4 		$43.7M Buy
437,092
+62,167
+17% +$6.58M 0.09% 265
2020
Q3 		$41.1M Buy
374,925
+22,408
+6% +$2.49M 0.09% 249
2020
Q2 		$37.3M Sell
352,517
-109,720
-24% -$11.3M 0.08% 257
2020
Q1 		$41.3M Sell
462,237
-362,410
-44% -$34.1M 0.11% 218
2019
Q4 		$82.3M Sell
824,647
-154,599
-16% -$14.6M 0.15% 147
2019
Q3 		$87.5M Buy
979,246
+61,981
+7% +$5.37M 0.17% 130
2019
Q2 		$75.6M Buy
917,265
+179,942
+24% +$14.1M 0.14% 160
2019
Q1 		$60.2M Buy
737,323
+96,279
+15% +$7.59M 0.11% 200
2018
Q4 		$48.6M Sell
641,044
-8,944
-1% -$698K 0.11% 210
2018
Q3 		$51.5M Buy
649,988
+483,231
+290% +$36.5M 0.1% 218
2018
Q2 		$11.7M Sell
166,757
-49,264
-23% -$3.54M 0.02% 819
2018
Q1 		$15.1M Sell
216,021
-112,672
-34% -$7.8M 0.03% 760
2017
Q4 		$22.4M Sell
328,693
-599,377
-65% -$40.4M 0.04% 589
2017
Q3 		$62.9M Buy
928,070
+617,619
+199% +$39M 0.11% 213
2017
Q2 		$21.2M Buy
310,451
+273,756
+746% +$17.9M 0.04% 581
2017
Q1 		$2.29M Sell
36,695
-114
-0.3% -$6.64K ﹤0.01% 1676
2016
Q4 		$2.01M Buy
+36,809
New +$2.09M ﹤0.01% 1787

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Russell Investments Group's AZN Position: Q2 2026 in Review

Russell Investments Group increased its AstraZeneca (AZN) stake by 1.5% in Q2 2026, buying an estimated $5.75M and bringing the position to 2,033,587 shares worth $382M. The position accounts for 0.34% of the portfolio, ranked #38.

Russell Investments Group first reported a position in AZN in Q4 2016 and has held it in 39 quarters since. The position peaked at $389M in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Russell Investments Group held 2,033,587 shares of AstraZeneca worth $382M as of Q2 2026.
  • Russell Investments Group bought 30,559 AstraZeneca shares in Q2 2026, an estimated $5.75M.
  • AstraZeneca made up 0.34% of Russell Investments Group's portfolio in Q2 2026, its #38 holding.
  • Russell Investments Group first reported a position in AstraZeneca in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's AstraZeneca position peaked at $389M in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.